Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Origoni

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Schizophrenia Research|May 7, 2011
Artemisinin reduces the level of antibodies to gliadin in schizophreniaFaith Dickerson, Cassie Stallings, Crystal Vaughan, et al.
Schizophrenia Research|December 11, 2012
C-reactive protein is elevated in schizophreniaFaith Dickerson, Cassie Stallings, Andrea Origoni, et al.
Bipolar Disorders|October 10, 2013
Antibodies to Toxoplasma gondii in individuals with maniaFaith Dickerson, Cassie Stallings, Andrea Origoni, et al.
The Journal of Nervous and Mental Disease|July 17, 2007
The association between cognitive functioning and occupational status in persons with a recent onset of psychosisFaith B Dickerson, Cassie Stallings, Andrea Origoni, et al.
Bipolar Disorders|February 20, 2026
Risk Factors for Natural Cause Mortality in Bipolar DisorderFaith Dickerson, Sabahat Khan, Andrea Origoni, et al.
The Journal of Nervous and Mental Disease|July 11, 2014
Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controlsFaith Dickerson, Cassie Stallings, Andrea Origoni, et al.
Scientific Reports|October 21, 2025
Risk factors for unnatural mortality in persons with serious mental illnessFaith Dickerson, Sabahat Khan, Andrea Origoni, et al.
JAMA Network Open|September 10, 2024
Risk Factors for Natural Cause Mortality in SchizophreniaFaith Dickerson, Sabahat Khan, Andrea Origoni, et al.
Schizophrenia Bulletin|May 9, 2025
The Association Between Psychotropic Medications and Cognitive Functioning in a Real-World Cohort of 869 Individuals with SchizophreniaFaith Dickerson, Andrea Origoni, Emily Katsafanas, et al.
Schizophrenia Research|September 27, 2025
The MATRICS Consensus Cognitive Battery (MCCB) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Convergent validityFaith Dickerson, Andrea Origoni, Emily Katsafanas, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Schizophrenia Research|May 7, 2011
Artemisinin reduces the level of antibodies to gliadin in schizophreniaFaith Dickerson, Cassie Stallings, Crystal Vaughan, et al.
Schizophrenia Research|December 11, 2012
C-reactive protein is elevated in schizophreniaFaith Dickerson, Cassie Stallings, Andrea Origoni, et al.
Bipolar Disorders|October 10, 2013
Antibodies to Toxoplasma gondii in individuals with maniaFaith Dickerson, Cassie Stallings, Andrea Origoni, et al.
The Journal of Nervous and Mental Disease|July 17, 2007
The association between cognitive functioning and occupational status in persons with a recent onset of psychosisFaith B Dickerson, Cassie Stallings, Andrea Origoni, et al.
Bipolar Disorders|February 20, 2026
Risk Factors for Natural Cause Mortality in Bipolar DisorderFaith Dickerson, Sabahat Khan, Andrea Origoni, et al.
The Journal of Nervous and Mental Disease|July 11, 2014
Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controlsFaith Dickerson, Cassie Stallings, Andrea Origoni, et al.
Scientific Reports|October 21, 2025
Risk factors for unnatural mortality in persons with serious mental illnessFaith Dickerson, Sabahat Khan, Andrea Origoni, et al.
JAMA Network Open|September 10, 2024
Risk Factors for Natural Cause Mortality in SchizophreniaFaith Dickerson, Sabahat Khan, Andrea Origoni, et al.
Schizophrenia Bulletin|May 9, 2025
The Association Between Psychotropic Medications and Cognitive Functioning in a Real-World Cohort of 869 Individuals with SchizophreniaFaith Dickerson, Andrea Origoni, Emily Katsafanas, et al.
Schizophrenia Research|September 27, 2025
The MATRICS Consensus Cognitive Battery (MCCB) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Convergent validityFaith Dickerson, Andrea Origoni, Emily Katsafanas, et al.
Pageof 6